Dear Industry Partners,

On behalf of the EBV Association and the KSHV research community, we invite your company to partner with us and support the International Symposium on EBV & KSHV, Related Agents and Diseases – 3rd Joint Meeting, June 29 – July 3, 2024 at the Hilton Boston Park Plaza, Boston, USA.

This 3rd joint meeting of the EBV Association and the KSHV Conference Series will serve as the premier forum for the exchange of new developments in the fields of EBV & KSHV and related agents and diseases and is expected to attract 350-400 participants. Marking the 60th Anniversary of the Discovery of the Epstein-Barr virus (EBV) as well as the 30th Anniversary of the Discovery of the Kaposi’s Sarcoma Herpesvirus (KSHV), the meeting goals are to enhance interactions among scientists in these related field and promote interdisciplinary communication and collaborations among researchers with expertise that span molecular virus biology, innate and adaptive immunobiology, animal models of pathogenesis, pathology, epidemiology and therapeutic strategies.

The meeting encourages the presentation of data before publication to enable open discussion and feedback from a field of experts, in addition to fostering the development of scientists in training scientific communication skills. Networking opportunities will be structured for trainees to interact with senior faculty at academic institutions and scientists from industry and government. Senior scientist, clinicians and trainees at all levels are invited to participate and attend as well as attendees with knowledge and interests outside the EBV/KSHV community to bring perspective and instructive comparisons.

We are therefore looking forward to partnering with industry representatives to discuss the most recent developments, educate researchers on the various tools and technologies available, and foster collaborations between industry, academia and trainees, ultimately benefitting patients’ healthcare worldwide.

Yours sincerely,

Co-Chairs:

• Benjamin E. Gewurz, MD, PhD, Associate Professor of Medicine, Brigham & Women’s Hospital and Harvard Medical School, Boston, USA
• Kenneth M. Kaye, MD, Professor, Harvard Medical School, Infectious Disease, Boston, USA

Organizing Committee:

• Ann M. Moormann, PhD, MPH, Professor, Department of Medicine, UMass Chan Medical School, USA
• Mandy Muller, PhD, Associate Professor, Department of Microbiology, University of Massachusetts, Amherst, USA
• Erle S. Robertson, PhD, Harry P. Schenck Professor in Otorhinolaryngology, Program Leader, Tumor Virology Training Program, Perelman School of Medicine, University of Pennsylvania, USA
• Bo Zhao, PhD, Associate Professor of Medicine, Brigham and Women’s Hospital, Department Medicine, USA

Sponsorship Levels

Platinum Sponsor: $25,000 – Sponsorship Benefits would include:

• Acknowledgement as a Platinum sponsor with a large logo in the Final Program & Abstract Book and Website www.ebv.ksvirus.org,  intersession slides and signage at the meeting
• Five complimentary registrations
• Full page color inside cover ad in the Final Program & Abstract books
• Optional – tabletop exhibit in the Exhibit Hall
• Opportunity to participate in a 30 minute industry sponsored session on a topic of interest to the participants and with final approval by the organizing committee

Gold Sponsor: $20,000 – Sponsorship Benefits would include:

• Acknowledgement as a Gold sponsor with a large logo in the Final Program & Abstract Book and Website www.ebv.ksvirus.org,  intersession slides and signage at the meeting
• Four complimentary registrations
• Full page ad in the Final Program &b Abstract books
• Optional – tabletop exhibit in the Exhibit Hall

Silver Sponsor: $15,000 – Sponsorship Benefits would include:

• Acknowledgement as a Silver sponsor with a large logo in the Final Program & Abstract Book and Website www.ebv.ksvirus.org,  intersession slides and signage at the meeting
• Three complimentary registrations
• Half page ad in the Final Program & Abstract books

Bronze Sponsor: $10,000 – Sponsorship Benefits would include:

• Acknowledgement as a Bronze sponsor with a medium logo in the Final Program & Abstract Book and Website www.ebv.ksvirus.org,  intersession slides and signage at the meeting
• Three complimentary registrations

Sponsor: $5,000 – Sponsorship Benefits would include:

• Acknowledgement as a sponsor with a small logo in the Final Program & Abstract Book and Website www.ebv.ksvirus.org,  intersession slides and signage at the meeting
• Two complimentary registrations

Tabletop Exhibitor: $5,000 – Exhibitor Benefits would include:

• Acknowledgement as an Exhibitor with a small logo in the Final Program & Abstract Book and Website www.ebv.ksvirus.org,  intersession slides and signage at the meeting
• One 6′ X 30″ tabletop exhibit with 2 chairs and electrical outlet
• Two complimentary registrations

Tabletop Exhibitor: $3,750 – Exhibitor Benefits would include:

• Acknowledgement as an Exhibitor with a small logo in the Final Program & Abstract Book and Website www.ebv.ksvirus.org,  intersession slides and signage at the meeting
• One 6′ X 30″ tabletop exhibit with 2 chairs and electrical outlet
• One complimentary registration

The program starts Saturday evening, June 29th with an opening Keynote and welcome reception. On Sunday morning we have the Grand Ballroom B available for set up of the tabletops, opening for the 10 AM coffee break on Sunday. Exhibits will be available tfor participants to visit all day Sunday, Monday and Tuesday, during the coffee breaks and evening poster session receptions, with all food and beverage served in the Exhibit room. Tear down of the tabletops will be on Tuesday evening.

Contact the Meeting Organizer:

Rhema Association Management is the official meeting organizer of EBV-KSHV Joint Meeting  to process registrations, abstract management, exhibition and sponsorship.

Joan Oefner, Conference Manager
E-mail
Tel. +49 171-1049-181
WhatsApp: +49 171-1049-181

EBV-KSHV Joint Meeting is organized under the auspices of the International Asso Res On Epstein Barr Virus & Asso Diseases Inc 
1359 E PERRYS HOLLOW ROAD
SALT LAKE CITY, UT 84103 USA

TAX ID 59-2821283